580 related articles for article (PubMed ID: 27212032)
1. Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.
Cao C; Vasilatos SN; Bhargava R; Fine JL; Oesterreich S; Davidson NE; Huang Y
Oncogene; 2017 Jan; 36(1):133-145. PubMed ID: 27212032
[TBL] [Abstract][Full Text] [Related]
2. HDAC5-LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cells.
Cao C; Wu H; Vasilatos SN; Chandran U; Qin Y; Wan Y; Oesterreich S; Davidson NE; Huang Y
Int J Cancer; 2018 Sep; 143(6):1388-1401. PubMed ID: 29633255
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells.
Vasilatos SN; Katz TA; Oesterreich S; Wan Y; Davidson NE; Huang Y
Carcinogenesis; 2013 Jun; 34(6):1196-207. PubMed ID: 23354309
[TBL] [Abstract][Full Text] [Related]
4. The deubiquitinase USP28 stabilizes LSD1 and confers stem-cell-like traits to breast cancer cells.
Wu Y; Wang Y; Yang XH; Kang T; Zhao Y; Wang C; Evers BM; Zhou BP
Cell Rep; 2013 Oct; 5(1):224-36. PubMed ID: 24075993
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells.
Huang Y; Vasilatos SN; Boric L; Shaw PG; Davidson NE
Breast Cancer Res Treat; 2012 Feb; 131(3):777-89. PubMed ID: 21452019
[TBL] [Abstract][Full Text] [Related]
6. The histone demethylase LSD1 is required for estrogen-dependent S100A7 gene expression in human breast cancer cells.
Yu SE; Jang YK
Biochem Biophys Res Commun; 2012 Oct; 427(2):336-42. PubMed ID: 23000163
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of LSD1 at Ser112 is crucial for its function in induction of EMT and metastasis in breast cancer.
Feng J; Xu G; Liu J; Zhang N; Li L; Ji J; Zhang J; Zhang L; Wang G; Wang X; Tan J; Huang B; Lu J; Zhang Y
Breast Cancer Res Treat; 2016 Oct; 159(3):443-56. PubMed ID: 27572339
[TBL] [Abstract][Full Text] [Related]
8. OTUD7B Deubiquitinates LSD1 to Govern Its Binding Partner Specificity, Homeostasis, and Breast Cancer Metastasis.
Gong Z; Li A; Ding J; Li Q; Zhang L; Li Y; Meng Z; Chen F; Huang J; Zhou D; Hu R; Ye J; Liu W; You H
Adv Sci (Weinh); 2021 Aug; 8(15):e2004504. PubMed ID: 34050636
[TBL] [Abstract][Full Text] [Related]
9. Class I lysine deacetylases promote glucocorticoid-induced transcriptional repression through functional interaction with LSD1.
Patrick NM; Griggs CA; Icenogle AL; Gilpatrick MM; Kadiyala V; Jaime-Frias R; Smith CL
J Steroid Biochem Mol Biol; 2017 Mar; 167():1-13. PubMed ID: 27645313
[TBL] [Abstract][Full Text] [Related]
10. LSD1 coordinates with the SIN3A/HDAC complex and maintains sensitivity to chemotherapy in breast cancer.
Yang Y; Huang W; Qiu R; Liu R; Zeng Y; Gao J; Zheng Y; Hou Y; Wang S; Yu W; Leng S; Feng D; Wang Y
J Mol Cell Biol; 2018 Aug; 10(4):285-301. PubMed ID: 29741645
[TBL] [Abstract][Full Text] [Related]
11. miR-708/LSD1 axis regulates the proliferation and invasion of breast cancer cells.
Ma L; Ma S; Zhao G; Yang L; Zhang P; Yi Q; Cheng S
Cancer Med; 2016 Apr; 5(4):684-92. PubMed ID: 26833707
[TBL] [Abstract][Full Text] [Related]
12. Oncogene LSD1 is epigenetically suppressed by miR-137 overexpression in human non-small cell lung cancer.
Zhang X; Zhang X; Yu B; Hu R; Hao L
Biochimie; 2017 Jun; 137():12-19. PubMed ID: 28223039
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of lysine-specific demethylase 1 promotes androgen-independent transition of human prostate cancer LNCaP cells through activation of the AR signaling pathway and suppression of the p53 signaling pathway.
Li X; Li T; Chen D; Zhang P; Song Y; Zhu H; Xiao Y; Xing Y
Oncol Rep; 2016 Jan; 35(1):584-92. PubMed ID: 26534764
[TBL] [Abstract][Full Text] [Related]
14. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer.
Wang Y; Zhang H; Chen Y; Sun Y; Yang F; Yu W; Liang J; Sun L; Yang X; Shi L; Li R; Li Y; Zhang Y; Li Q; Yi X; Shang Y
Cell; 2009 Aug; 138(4):660-72. PubMed ID: 19703393
[TBL] [Abstract][Full Text] [Related]
15. Silencing of LSD1 gene modulates histone methylation and acetylation and induces the apoptosis of JeKo-1 and MOLT-4 cells.
Zou ZK; Huang YQ; Zou Y; Zheng XK; Ma XD
Int J Mol Med; 2017 Aug; 40(2):319-328. PubMed ID: 28627608
[TBL] [Abstract][Full Text] [Related]
16. HDAC5 Loss Impairs RB Repression of Pro-Oncogenic Genes and Confers CDK4/6 Inhibitor Resistance in Cancer.
Zhou Y; Jin X; Ma J; Ding D; Huang Z; Sheng H; Yan Y; Pan Y; Wei T; Wang L; Wu H; Huang H
Cancer Res; 2021 Mar; 81(6):1486-1499. PubMed ID: 33419772
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase 5 promotes the proliferation of glioma cells by upregulation of Notch 1.
Liu Q; Zheng JM; Chen JK; Yan XL; Chen HM; Nong WX; Huang HQ
Mol Med Rep; 2014 Oct; 10(4):2045-50. PubMed ID: 25050565
[TBL] [Abstract][Full Text] [Related]
18. LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
Boulding T; McCuaig RD; Tan A; Hardy K; Wu F; Dunn J; Kalimutho M; Sutton CR; Forwood JK; Bert AG; Goodall GJ; Malik L; Yip D; Dahlstrom JE; Zafar A; Khanna KK; Rao S
Sci Rep; 2018 Jan; 8(1):73. PubMed ID: 29311580
[TBL] [Abstract][Full Text] [Related]
19. Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.
Li Q; Shi L; Gui B; Yu W; Wang J; Zhang D; Han X; Yao Z; Shang Y
Cancer Res; 2011 Nov; 71(21):6899-908. PubMed ID: 21937684
[TBL] [Abstract][Full Text] [Related]
20. FBXO24 Suppresses Breast Cancer Tumorigenesis by Targeting LSD1 for Ubiquitination.
Dong B; Song X; Wang X; Dai T; Wang J; Yu Z; Deng J; Evers BM; Wu Y
Mol Cancer Res; 2023 Dec; 21(12):1303-1316. PubMed ID: 37540490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
